HOTCHKIS & WILEY, a prominent investment firm established in 1980 in Los Angeles, is renowned for its dedicated approach to value investing. The firm prioritizes undervalued companies with strong tangible assets, sustainable cash flow, and potential for business performance improvement. Their latest 13F filing for the third quarter of 2024 reveals significant portfolio adjustments, reflecting their strategic investment decisions.
HOTCHKIS & WILEY added a total of 75 stocks to their portfolio this quarter. Noteworthy new additions include:
HOTCHKIS & WILEY also increased their stakes in a total of 161 stocks, with significant increases in:
In the third quarter of 2024, HOTCHKIS & WILEY completely exited 75 holdings, including:
Moreover, HOTCHKIS & WILEY reduced positions in 235 stocks. The most significant reductions include:
As of the third quarter of 2024, HOTCHKIS & WILEY's portfolio included 482 stocks. The top holdings were 4.02% in F5 Inc (NASDAQ:FFIV), 3.26% in $Citigroup Inc(C-N)$ (NYSE:C), 2.93% in Telefonaktiebolaget L M Ericsson (NASDAQ:ERIC), 2.57% in General Motors Co (NYSE:GM), and 2.49% in CVS Health Corp (NYSE:CVS). The holdings are mainly concentrated across 11 industries, including Financial Services, Technology, Healthcare, and more.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。